This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Alprenolol
From Proteopedia
(Difference between revisions)
| Line 3: | Line 3: | ||
<scene name='10/1011229/Cv/2'>Human beta2 adrenergic receptor in complex with the neutral antagonist alprenolol</scene> ([[3nya]]). | <scene name='10/1011229/Cv/2'>Human beta2 adrenergic receptor in complex with the neutral antagonist alprenolol</scene> ([[3nya]]). | ||
| + | |||
| + | <scene name='10/1011229/Binding_site/1'>Alprenolol binding site</scene>. | ||
</StructureSection> | </StructureSection> | ||
== References == | == References == | ||
<references/> | <references/> | ||
Revision as of 10:01, 23 November 2023
| |||||||||||
References
- ↑ Elmros T, Hörstedt P, Winblad B. Scanning electron microscopic study of virulent and avirulent colonies of Neisseria gonorrhoeae. Infect Immun. 1975 Sep;12(3):630-7. PMID:809360 doi:10.1128/iai.12.3.630-637.1975
- ↑ Hickie JB. Alprenolol ("aptin") in angina pectoris. A double-blind multicentre trial. Med J Aust. 1970 Aug 8;2(6):268-72 PMID:4393977
